Skip to main content
FERMENTA BIOTECH LIMITED logo

FERMENTA BIOTECH LIMITED — Investor Relations & Filings

Ticker · FERMENTA ISIN · INE225B01021 LEI · 335800VNTNWW8G1U9314 BSE.NS Manufacturing
Open in API
Filings indexed 671 across all filing types
Latest filing 2024-04-24 Regulatory Filings
Country IN India
Listing BSE.NS FERMENTA

About FERMENTA BIOTECH LIMITED

https://fermentabiotech.com

Fermenta Biotech Limited is a specialized biotechnology company primarily focused on the development and manufacture of Vitamin D3 (Cholecalciferol). As one of the few vertically integrated manufacturers globally, the company produces Vitamin D3 for diverse applications, including pharmaceuticals, dietary supplements, human nutrition, and animal feed. Beyond its core Vitamin D3 portfolio, the company offers a range of specialty enzymes, particularly for the synthesis of beta-lactam antibiotics, and provides environmental solutions through its biotechnology expertise. Fermenta Biotech emphasizes high-quality standards, maintaining various international certifications for its manufacturing facilities. Its product offerings extend to premixes and value-added formats designed to meet specific formulation requirements. The company serves a global clientele, leveraging its research and development capabilities to innovate in the fields of nutrition and biotechnology.

Recent filings

Filing Released Lang Actions
Intimation under regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015
Regulatory Filings Classification · 95% confidence The document is a short communication addressed to the stock exchange (BSE Limited) regarding the issue of duplicate share certificates to shareholders. It references Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate matters. The content is about share certificate issuance and does not contain financial data, management discussion, or report publication. It is not an announcement of a report publication but a regulatory compliance notification related to share certificates. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-04-24 English
Details of issue of duplicate share certificate to the Shareholder
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to the stock exchange (BSE Limited) regarding an intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It informs about the issue of a duplicate share certificate to a shareholder. The content is a regulatory notification about share certificate issuance, not a financial report, earnings release, or management discussion. It does not contain financial data or detailed report content but is a compliance-related announcement. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2024-04-19 English
Compliance certificate for the period from April 01, 2023 to March 31, 2024.
Regulatory Filings Classification · 95% confidence The document is a compliance certificate addressed to the stock exchange (BSE Limited) regarding Regulation 7(3) of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. It confirms the maintenance of share transfer facilities for the period April 1, 2023 to March 31, 2024. The document is short (1845 characters) and is a formal attestation or certification rather than a financial report or detailed filing. It does not contain financial statements, management discussion, or detailed disclosures. It is primarily a regulatory compliance certificate. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS).
2024-04-19 English
Pursuant to Regulation 40(9) of the Listing Regulations, we are enclosing certificate dated April 15, 2024 issued by M/s. V. N. Deodhar & Co., Company Secretaries for the period from April ....
Regulatory Filings Classification · 95% confidence The document is a Compliance Certificate issued under Regulation 40(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the financial year ended March 31, 2024. It certifies the handling of share certificates related to transmission, transposition, sub-division, consolidation, change of name, and deletion of name by the Registrar & Transfer Agents. The document is a formal certificate confirming compliance with regulatory requirements rather than a full financial report or announcement of voting results, management changes, or other categories. It is not an Annual Report, Interim Report, or Earnings Release. It is also not a report publication announcement or a regulatory filing in the sense of officer certifications or miscellaneous filings. The document fits best under the category of Regulatory Filings (RNS) as it is a compliance certificate related to listing obligations but does not fall under other more specific categories.
2024-04-19 English
Certificate under Regulation 74(5) of SEBI (Depositories and Participants), Regulations 2018 for the quarter ended March 31, 2024.
Regulatory Filings Classification · 95% confidence The document is a certificate issued under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, confirming the dematerialization of securities for the quarter ended March 31, 2024. It is addressed to stock exchanges and depositories and includes confirmation from the Registrar and Transfer Agent. The document is a regulatory compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements or management discussion but is a formal attestation related to securities dematerialization. Given its nature as a compliance certificate under SEBI regulations, it fits best under Regulatory Filings (RNS). The document length is short (3814 characters) and it is not an announcement of a report but a certificate itself, so it is not a Report Publication Announcement (RPA).
2024-04-19 English
Intimation under regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015
Regulatory Filings Classification · 100% confidence The document is a short notice informing the stock exchange about the loss of share certificates, pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It contains details of the lost share certificates and is intended for regulatory compliance and record-keeping. It does not contain financial data, management discussion, voting results, or any report content. This type of filing is a regulatory announcement related to share certificates and does not fit into categories like Annual Report, Earnings Release, or Share Issue. Therefore, it best fits under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-04-11 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.